This is a great description of the M&A market year-to-date. I look forward to seeing the update throughout May/June.
After the M&A market’s disappointing end to 2022, many predicted that the slowed deal activity would carry over to 2023 and that it would be another down year. Even those who thought 2023 might get off to a slow start, staying closer to 2022 levels, could have thought that deal volumes would ultimately mimic pre-2021 levels. It was hard to imagine M&A deal volumes dropping lower than those at the end of 2022, but that is exactly what happened.
View referenced article
Author(s)
Related Insights
August 18, 2026
PTAB Trial Insights
Navigating IPR Discretionary Denial White Waters with Examiner Error: A Practitioner's Guide
Decided five years before the surge of discretionary denial decisions in 2025, the second prong of Advanced Bionics requires the Director to determine “whether the petitioner has demonstrated that the Office erred in a manner material to the patentability of challenged claims” when the same or substantially the same art or arguments previously were presented to the Office.
August 17, 2026
Foley Viewpoints
Recent SAT Publications on Fraudulent CFDIs – Immediate Risks for Your Business
The Tax Administration Service (SAT) continues to audit taxpayers as part of the new expedited domiciliary audit procedure, through which it can determine whether the digital tax invoices (CFDI) issued by such taxpayers are fraudulent.
August 17, 2026
Health Care Law Today
FQHCs: The Expanding Landscape of Medicare Billing Outside of PPS for Care Management Services
Federally Qualified Health Centers (FQHCs) are primarily reimbursed by Medicare through the Prospective Payment System (PPS), which pays a per-visit rate to cover a typical bundle of medically necessary services provided during a patient encounter. Increasingly, however, FQHCs have opportunities to bill certain care management services to Medicare outside the PPS bundle. The steady expansion of these services over the last decade is one of the most significant changes to Medicare FQHC reimbursement since the Affordable Care Act (ACA).